Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy
Allyson B. Brahs, BS; and Cynthia Lazzaro, DO
A closer look at the first NCE approved to treat acne in more than a decade.
Joshua Zeichner, MD
The plastic surgery field is confronting renewed focus on risks for a rare cancer. Here’s an update.
Jonathan Wolfe, MD
Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?
Technology to date may not have streamlined patient care and practice management as expected, but emerging solutions are paving the way for greater efficiency, accuracy and ease-of-use.
Do we have a certified crisis in medicine?
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Lynn McKinley-Grant MD, MA, FAAD
DermTube Journal Club
As more and more treatments become available for hyperhidrosis, Ted Lain, MD says there is still a need to educate patients about what this condition...
Ted Lain, MD; and Joshua Zeichner, MD, FAAD
From patient education to novel therapeutics, there are promising new approaches to patient care.
New and emerging treatment approaches offer hope for this challenging condition.
Nada Elbuluk, MD, MSc
A brief review of dermatologic healthcare disparities in the lesbian, gay, bisexual, and transgender (LGBT) community and racial minority groups, including African Americans, Hispanics, and Asian/Pacific Islanders.
Maria L. Espinosa, BS; and Peter A. Lio, MD
Skin cancer diagnosis and treatment may be delayed in people of color, contributing to poor prognosis.
Kesha Buster, MD, FAAD; and Ekene Ezenwa, BS
Why A 401(k) can cause liability for dermatologists and how to mitigate this risk
Adam Braunscheidel, CFP; and David B. Mandell, JD, MBA
Pratices that analyze the client experience can enhance that experience to the benefit of the practice and patient care.